Spots Global Cancer Trial Database for A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)
Official Title: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2 Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)
Study ID: NCT00571675
Conditions
Study Description
Brief Summary: This is a randomized, double-blind, placebo-controlled, multinational Phase 2 study to evaluate and compare oral AT-101 in combination with docetaxel and prednisone versus docetaxel and prednisone plus placebo in the treatment of chemotherapy-naïve metastatic hormone-refractory prostate cancer, who have received hormonal therapy but not chemotherapy.
Detailed Description: Further Study Details provided by Ascenta.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Colorado Springs, Colorado, United States
, New Port Richey, Florida, United States
, Ocoee, Florida, United States
, Fishers, Indiana, United States
, Burnsville, Minnesota, United States
, Las Vegas, Nevada, United States
, Albuquerque, New Mexico, United States
, Las Cruces, New Mexico, United States
, Raleigh, North Carolina, United States
, Kettering, Ohio, United States
, Eugene, Oregon, United States
, Spartanburg, South Carolina, United States
, Amarillo, Texas, United States
, Arlington, Texas, United States
, Austin, Texas, United States
, Dallas, Texas, United States
, Denton, Texas, United States
, Midland, Texas, United States
, Paris, Texas, United States
, Webster, Texas, United States
, Fairfax, Virginia, United States
, Norfolk, Virginia, United States
, Kennewick, Washington, United States
, Vancouver, Washington, United States
, Barnaul, , Russian Federation
, Engels, , Russian Federation
, Kazan, , Russian Federation
, Kursk, , Russian Federation
, Kuzmolovsky, , Russian Federation
, Moscow, , Russian Federation
, Sochi, , Russian Federation
, St. Petersburg, , Russian Federation
, Stavropol, , Russian Federation
, Voronezh, , Russian Federation
, Yekaterinburg, , Russian Federation
Contact Details
Name: Lance Leopold, MD
Affiliation: Ascenta Therapeutics
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
